As 2010 comes to an end, and the year's layoff total tops 50,000, we're releasing our fourth annual layoffs list, highlighting the 10 largest job cut announcements by company. AstraZeneca takes the top spot this year, marking the third time in four years the drugmaker has made our layoffs list. And after two years on top, Pfizer has fallen to second place as it continues to integrate with Wyeth. As Big Pharma prepares for the patent cliff, many blamed their increasing job cuts on pharma's new focus: emerging markets. Some buffered the impending job losses with transfers and jobs created in new markets.
Sales jobs in particular were hit hard again this year, culminating in the recent report of Sanofi's cattle-call approach to informing sales reps of their status.
Half of this year's list are names that didn't appear last year: Roche, Bayer, Abbott, Takeda and Novartis.
01. AstraZeneca - 8,550 02. Pfizer - - - - - -8,480 03. GSK - - - - - - -5,201 04. Roche - - - - - 4,800 05. Bayer - - - - - 4,500 |
06. Abbott - - - 3,000 07. Sanofi - - - 2,500 08. Takeda - - -1,400 09. Novartis - - 1,400 10. BMS - - - - - - 840 |
Click en cada una de ellas para conocer más detalles.
Más
Ver tambien
Entradas
1 comentario:
¿Y porqué no, "empleados-moneda de cambio"?....
Que tú (Pais/Autonomia/Ministerio) me rebajas el precio de los farmacos de forma arbitraria y unilateral, con la consiguiente reducción de nuestros beneficios.....pues te ponemos 50.000 empleados en la calle y te jodes.
Si mas adelante "nos ponemos de acuerdo" volvemos a contratar y todos tan amigos......eso sí.... nadie protestará por los "cadáveres" dejados en el camino, pues esas personas y sus familias no importan a nadie.
Ex-empleado de Novartis
Publicar un comentario